QA: Intelgenx Technologies Corp in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001098880_2021_Intelgenx_Technologies_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001098880, Intelgenx Technologies Corp

  xvar xval
0 AssetsCurrent 4,305,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,851,000
3 remainder_Assets 962,000
4 LiabilitiesCurrent 4,368,000
5 LiabilitiesNoncurrent 482,000
6 remainder_Liabilities 7,221,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,257,369
9 ResearchAndDevelopmentExpense 2,616,936
10 remainder_Expenses 732,294
11 remainder_Revenues 1,771,618
12 remainder_NetIncome -831,934
13 remainder_ComprehensiveNetIncome 142,453
  yvar yval
0 Assets 11,118,000
1 Liabilities 12,071,000
2 Expenses 7,606,599
3 Revenues 1,771,618
4 StockholdersEquity -953,000
5 NetIncome -6,666,915
6 ComprehensiveNetIncome -6,595,688
7 BaseVar 16,770,802
8 EconomicCapitalRatiobeforeLimitedLiability -0.748
9 EconomicCapitalRatio 1.35

Edgar->Model Mapping

Feature Distribution

Change over Time